Analysts: Auxilium Pharmaceuticals Inc (AUXL.OQ)

AUXL.OQ on NASDAQ Stock Exchange Global Select Market

19.65USD
1 Aug 2013
Price Change (% chg)

$1.29 (+7.03%)
Prev Close
$18.36
Open
$19.58
Day's High
$20.93
Day's Low
$18.65
Volume
788,685
Avg. Vol
203,044
52-wk High
$26.55
52-wk Low
$13.88

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.00 December 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 7 7
(2) OUTPERFORM 5 5 3 3
(3) HOLD 2 2 3 2
(4) UNDERPERFORM 0 0 0 1
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 1.87 1.87 1.93 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 14 103.31 107.10 94.81 80.36
Quarter Ending Dec-13 14 113.50 129.83 105.00 87.74
Year Ending Dec-13 15 372.72 385.20 347.70 362.81
Year Ending Dec-14 15 470.05 568.40 394.52 438.24
Earnings (per share)
Quarter Ending Sep-13 9 -0.00 0.11 -0.10 -0.05
Quarter Ending Dec-13 9 0.10 0.20 -0.02 0.04
Year Ending Dec-13 9 -0.13 0.07 -0.43 0.20
Year Ending Dec-14 10 0.60 1.14 0.10 0.82

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 81.23 66.17 15.06 18.54
Quarter Ending Dec-12 171.17 172.50 1.33 0.78
Quarter Ending Sep-12 79.34 71.04 8.30 10.46
Quarter Ending Jun-12 73.95 78.20 4.25 5.74
Quarter Ending Mar-12 71.21 73.60 2.39 3.36
Earnings (per share)
Quarter Ending Mar-13 0.02 -0.12 0.14 734.92
Quarter Ending Dec-12 1.72 1.83 0.11 6.26
Quarter Ending Sep-12 -0.05 -0.21 0.16 -358.52
Quarter Ending Jun-12 -0.06 0.16 0.22 -366.67
Quarter Ending Mar-12 -0.11 -0.04 0.07 -65.10

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 103.31 103.31 103.72 104.08 80.36
Quarter Ending Dec-13 113.50 113.50 113.82 114.70 87.74
Year Ending Dec-13 372.72 372.72 374.30 375.67 362.81
Year Ending Dec-14 470.05 470.05 470.94 462.94 438.24
Earnings (per share)
Quarter Ending Sep-13 -0.00 -0.00 -0.00 -0.02 -0.05
Quarter Ending Dec-13 0.10 0.10 0.10 0.10 0.04
Quarter Ending Dec-13 -0.13 -0.13 -0.13 -0.16 0.20
Quarter Ending Dec-14 0.60 0.60 0.60 0.41 0.82

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 1 2
Quarter Ending Dec-13 0 0 1 2
Year Ending Dec-13 0 0 0 2
Year Ending Dec-14 0 0 2 1
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks